Braveheart Bio
BRVE20.0204.87% ( +0.930 )
已收盘: 10月9日 16:00:00 (美东)全部股东
股东类型
- 风投/私募60.44%
- 公众及其他15.34%
- 个人与内部人士14.88%
- 上市公司9.09%
- 机构投资者0.24%
主要股东
| 股东 | |||||
|---|---|---|---|---|---|
Forbion Capital Partners B.V. | 26.74% | 2,182.60 万 | 23.40% | +2,157.43 万 | |
OrbiMed Advisors LLC | 14.91% | 1,217.52 万 | -- | +1,217.52 万 | |
Andreessen Horowitz LLC | 12.53% | 1,023.24 万 | -- | +1,023.24 万 | |
Travis MurdochCEO, President & Director | 10.21% | 833.36 万 | 14.79% | +645.00 万 | |
Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 9.09% | 742.01 万 | -- | +742.01 万 | |
Frazier Life Sciences Management, LP | 6.26% | 510.74 万 | -- | +510.74 万 | |
Jason ColomaFormer Director | 1.35% | 110.05 万 | 1.99% | +84.92 万 | |
David MalekDirector | 1.24% | 101.33 万 | 1.82% | +78.29 万 | |
James RickeyChief Financial Officer | 0.86% | 70.36 万 | 1.19% | +54.93 万 | |
Christopher ViehbacherIndependent Chairman | 0.75% | 60.95 万 | 1.30% | +45.51 万 | |
Michele AndersonChief Development Officer | 0.41% | 33.22 万 | 0.60% | +25.66 万 | |
Charles Schwab Investment Management, Inc. | 0.16% | 12.97 万 | -- | +12.97 万 | |
David LubnerIndependent Director | 0.07% | 5.56 万 | -- | +5.56 万 | |
Vanguard Capital Management, LLC | 0.06% | 5.26 万 | -- | +5.26 万 | |
FMR LLC | 0.02% | 1.28 万 | -- | +1.28 万 | |
Vanguard Portfolio Management, LLC | <0.01% | 1,076.00 | -- | +1,076.00 |